Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
D000085:Acetates; D000818:Animals; D001623:Betamethasone / Q000494:pharmacology; D001681:Biological Assay; D004304:Dosage Forms; D004339:Drug Compounding; D004357:Drug Synergism; D004952:Esters; D005069:Evaluation Studies as Topic; D005233:Fatty Alcohols / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009779:Occlusive Dressings; D009824:Ointments; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011409:Propylene Glycols / Q000494:pharmacology; D011833:Radiation Injuries, Experimental; D012867:Skin / Q000187:drug effects*; D012871:Skin Diseases / Q000188:drug therapy; D012882:Skin Tests; D014466:Ultraviolet Rays; D014631:Valerates / Q000494:pharmacology; D014662:Vasoconstrictor Agents
D000085:Acetates; D004304:Dosage Forms; D004952:Esters; D005233:Fatty Alcohols; D009824:Ointments; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011409:Propylene Glycols; D014631:Valerates; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D001623:Betamethasone